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Figure 2: A positive outcome from the application of Suprathel®, containing no signs of HTS.
• A retrospective chart review of 229 patients was performed by 
collecting:
– Extraneous data: Length of Stay, Age, Gender, Date of 
Surgery
– Dependent data: Depth of Burn, %Total Burn Surface Area 
(TBSA), Number of Consumed Units, Where Applied, Time 
to Healing, Pain Level through Healing, Wound Infection, 
Failure of Suprathel, Hypertrophic Scars (HTS)
• The study included all burn service patients who received the 
synthetic Suprathel® membrane between September 1, 2013 
and December 31, 2016.




Figure 3: A scar resulting from a deep second degree wound after the placement of Suprathel®.
Figure 4: A wound covered in the Suprathel® dressing. 
Suprathel® was 
applied in the 
operating room(OR) 
or burn center(BC) 















Figure 1: Burn Degree Diagram1
• Second degree burns require unique 
treatment due to pain during daily dressing 
changes, unpredictability of healing time, 
and scarring.
• The ideal treatment of second degree 
burns would be to:
− Decrease pain, limit dressing changes, 
allow assessment of healing progress, 
prevent infection, accelerate healing, 
improve long term outcome, save 
treatment cost.
• Second degree burns are typically treated 
with cream dressings and antibiotic 
ointment that require painful daily dressing 
changes to avoid bacteria growth. 
• Skin substitutes attempt to limit the amount 
of painful dressings and accelerate healing. 
Infection and integration have been the 
major drawbacks in past studies2.
• Suprathel® is a porous, fully synthetic 
biodegradable copolymer membrane made 
of DL-lactide which is FDA registered.
• Our objective was to review the use of 
Suprathel® in the LVHN Burn Center. 
RESULTS
DISCUSSION
• The application of this new skin substitute to second degree 
wounds offers a new simple option of treatment with better 
outcomes and less pain. 
• Suprathel® requires less frequent dressing changes, less pain 
medication and a lower infection rate as compared to cream 
dressing changes with antibiotic ointment.
• Pediatric patients and those who had Suprathel® application in 
BC had less pain, shorter time to healing, lower infection rate, 
and lower rate of HTS than adults or OR applications. This could 
be explained by the deeper burns that were generally treated in 
the OR, due to requiring additional procedures on other burn 
sites such as Split Thickness Skin Grafts (STSG). 
• The ability of Suprathel® to create an undisturbed location for 
healing contributed to a reduced time to healing as well as 
provided a translucent dressing to assess wound healing in 
progress. 
• 211 out of 229 patients did not acquire infections due to 
Suprathel’s® ability to create an optimal environment for healing 








Location of Suprathel 
Application
• 229 patients (141 male, 88 
female, 138 pediatric).
• 158 OR applications, 71 BC 
applications.
• Time to healing:12.4 days 
pediatric vs.16.4 days adults, 
11.0 days BC application vs.15.2 
days OR application. 
• Pain level: 0.6 pediatric vs. 2.7 
adults, 0.5 BC application vs.1.9 
OR application. 
• HTS: 10.1% pediatric vs. 14.29% 
adults, 4.23% BC application 










Failure of Suprathel® 5.24%
Avg. Time to Healing 13.98 days
